Systematically collected information used to understand patterns of substance use, substance use disorders, treatment needs, and drug market dynamics. This may include epidemiological data, service utilisation records, treatment outcomes, law enforcement intelligence, and public health surveillance. Data helps identify emerging trends, assess the effectiveness of prevention and treatment programmes, monitor trafficking and market activity, and guide evidence-informed policy and decision-making. Reliable data systems are essential for improving responses to substance use and ensuring that interventions are targeted, effective, and responsive to population needs.
Data
Prioritising Action on Alcohol for Health and Development
Webinar: EU Drug Market Report 2019
Description:
The aim of the webinar is to enable participants to understand the concept of the illicit drug market within the broader context of changing patterns of drug use, cultural and social factors and links to wider criminality; to describe to participants in detail the markets for the main drug types and the key points, and to talk about the opportunities for improvement of operational practices by using strat
Post Event Resources: 2019 NDARC Annual Research Symposium
EU Drug Markets Report 2019
National Drugs Library: The Irish Situation Factsheets
Launch of 'Sobriety, Abstinence & Moderation' Research Cluster
Responding to Global Stimulant Use: Challenges and Opportunities
2nd Global Conference on Addiction Medicine, Behavioral Health and Psychiatry
The 2nd Edition of Global Conference on Addiction Medicine, Behavioural health and Psychiatry” will be held on October 22-24, 2020 at Orlando, USA.
The theme of the event is “Unifying the new discoveries and advanced approaches towards Addiction and Psychiatry.”
9th International Research Conference on Adolescents and Adults with Fetal Alcohol Spectrum Disorders
Although there have been thousands of published articles on FASD, there still remains limited research specifically on adolescents and adults with FASD. As individuals diagnosed with FASD continue to age, the “need to know” across a broad spectrum of areas continues to be critically important for identifying clinically relevant research questions and directions.
Evidence in Action: CCSA Annual Report, 2018-2019